Interleukin 17A may play a role in the increased cardiovascular risk associated to chronic inflammatory diseases, such as rheumatoid arthritis, psoriasis, inflammatory bowel diseases [80]; its effect may be correlated to a decrease in CD39 activity and expression [79]. The gene discussed is ENTPD1; the disease is inflammatory bowel disease.